Microcatheter Market

Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027

Report Code: MD 7015 Nov, 2022, by marketsandmarkets.com

[164 Pages Report] The global microcatheter market is projected to reach USD  1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. This is attributed to the rising prevalence of cardiovascular and neurovascular diseases, an increasing number of invasive diagnostic and therapeutic procedures, and increased pharmaceutical and biotechnology industry research activities. Increasing sedentary lifestyle and advancements to replace open surgeries.

Global Microcatheter Market

Microcatheters Market

e- Estimated; p- Projected

To know about the assumptions considered for the study, Request for Free Sample Report

Microcatheter Market: Market Dynamics

Driver: Growing adoption of minimally invasive procedures

The past decade saw a significant increase in the preference for minimally invasive and over traditional surgical procedures. The variety of tools and techniques, skilled surgeons and technicians today make minimally invasive procedures easy. Furthermore, minimally invasive/nonsurgical alternatives offer advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. Government funds and reimburesemnet policies is also driving patients to opt for minimally invasive procedures.

Opportunities: Emerging markets

Emerging countries such as APAC,Japan  present significant opportunities for players operating in the microcatheter market. The demand for microcatheter market in these countries is increasing owing to rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing cardiovascular and neurovascular diseases. These countries are also home to a strong and qualified workforce and have a great knowledge of advance technologies.Furthermore, these countries have lenient policies for imports/exports and are underpenetrated in most aspects, which could help companies in brand development. Increasing developing technicians and the keen to know about new technologies is helping the regions to grow and update their technologies.

By product type, the delivery microcatheter segment accounted for the largest share during the forecast period.

In 2022, the delivery microcatheters segment accounted for the largest share of the microcatheters market in the US. This segment is projected to reach USD 442 million by 2027  from USD 332 million in 2022, at a CAGR of 5.9% during the forecast period.

Delivery microcatheters are easily available and easy to use as compared to other microcatheter. They work efficiently and have shown positive response in the indiviauls who are treated with delivery microcatheters.These microcatheters help to delivery diagnostic agents,such as contrast media and therapeutic agents,such as occlusion coils to peripheral and neuro vasculatures.

By End User Hospitals, the surgical centers and Specialty Clinics segment is expected to grow at the fastest rate during the forecast period.

In 2020, hospitals, surgical centers, & specialty clinics dominated the microcatheters market with a share of 72.8%. This end-user segment is projected to reach USD 799.5 million by 2027 from USD 548.5 million in 2020, at a CAGR of 5.7% during the forecast period. This end-user segment is also expected to grow at the highest CAGR of 5.7% during the forecast period. Growth in this segment is mainly due to the growing number of hospitals and specialty clinics in emerging countries; increasing prevalence of target diseases; and the growing number of cardiovascular, neurological, and oncological procedures. The ambulatory care centers segment is estimated to reach USD 283.5 million by 2027 from USD 202.3 million in 2020, at a CAGR of 5.1%.

North America is expected to be the largest market during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of 46.4% of the microcatheters market in 2020. Factors such as the increasing number of target diagnostic and interventional procedures performed in the region, high prevalence of diseases, rising geriatric population, and the high market availability of advanced interventional products (including microcatheters) are driving the growth of the microcatheters market in North America.

Microcatheters Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

As of 2021, prominent players in the market are Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan) among others.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, End Use, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan), Terumo Medical Corporation (Japan), Medtronic (US), Teleflex Incorporated (US), Johnson & Johnson(US), Penumbra(US), Cardinal Health (US), Kaneka Corporation( Japan)

This report has segmented the global microcatheters market based on product type, end user type, and region.

Global Microcatheters Market, by Product

  • Delivery Microcatheter
  • Aspiration Microcatheters
  • Diagnostic Microccatheters
  • Steerable Microcatheters

Global Microcatheters Market, by End User

  • Hospitals, Surgical Centers & Specialty Clinics
  • Ambulatory Care Centers

Microcatheters Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In 2021, Terumo medical corporation introduced new microcatheter named PG Pro Peripheral Microcatheter.
  • In 2020, Tri Saslus introduced new TriNav Microcatheter.
  • In 2021, Pneumbra received US FDA approval for its RED 62 Reperfusiom catheter.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION
                    FIGURE 2 MICROCATHETERS MARKET, BY REGION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH DATA
    2.2 RESEARCH DESIGN
          FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
           2.2.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
          FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 8 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION
    2.6 RESEARCH ASSUMPTIONS
    2.7 STUDY LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
          TABLE 1 LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY (Page No. - 37)
    FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

4 PREMIUM INSIGHTS (Page No. - 41)
    4.1 MICROCATHETERS MARKET OVERVIEW
          FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND
    4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT
          FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET
    4.3 MICROCATHETERS MARKET SHARE, BY END USER
          FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
    4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET
          FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022–2027

5 MARKET OVERVIEW (Page No. - 44)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in interventional cardiology
                    5.2.1.2 Expansion of patient population suffering from chronic illness
                    5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent regulatory guidelines and high cost of drug approval
                    5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally
    5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET
                    TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET
    5.4 PORTER’S FIVE FORCES ANALYSIS
           5.4.1 OVERVIEW
                    TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.4.2 THREAT OF NEW ENTRANTS
           5.4.3 THREAT OF SUBSTITUTES
           5.4.4 BARGAINING POWER OF SUPPLIERS
           5.4.5 BARGAINING POWER OF BUYERS
           5.4.6 DEGREE OF COMPETITION
    5.5 REGULATORY ANALYSIS
           5.5.1 US
                    TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.5.2 EUROPE
           5.5.3 JAPAN
                    TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    5.6 REIMBURSEMENT ANALYSIS
          TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS
    5.7 ECOSYSTEM ANALYSIS
    5.8 VALUE CHAIN ANALYSIS
           5.8.1 RESEARCH AND DEVELOPMENT
           5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT
           5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
                    FIGURE 21 VALUE CHAIN ANALYSIS
    5.9 SUPPLY CHAIN ANALYSIS
           5.9.1 PROMINENT COMPANIES
           5.9.2 SMALL & MEDIUM-SIZED COMPANIES
           5.9.3 END USERS
                    FIGURE 22 SUPPLY CHAIN ANALYSIS
    5.10 PATENT ANALYSIS
    5.11 TRADE ANALYSIS
           TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION)
           TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION)
    5.12 KEY CONFERENCES AND EVENTS IN 2022–2023
           TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX

6 MICROCATHETER MARKET, BY PRODUCT (Page No. - 58)
    6.1 INTRODUCTION
          TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
          TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
    6.2 DELIVERY MICROCATHETERS
           6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET
                    TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                    TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
    6.3 ASPIRATION MICROCATHETERS
           6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET
                    TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                    TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
    6.4 DIAGNOSTICS MICROCATHETERS
           6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET
                    TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                    TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
    6.5 STEERABLE MICROCATHETERS
           6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET
                    TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                    TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)

7 MICROCATHETERS MARKET, BY PRODUCT DESIGN (Page No. - 69)
    7.1 INTRODUCTION
          TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
    7.2 SINGLE LUMEN MICROCATHETERS
           7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET
                    TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 DUAL-LUMEN MICROCATHETERS
           7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET
                    TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)

8 MICROCATHETERS MARKET, BY APPLICATION (Page No. - 73)
    8.1 INTRODUCTION
          TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 CARDIOVASCULAR APPLICATIONS
           8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET
                    TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.3 NEUROVASCULAR APPLICATIONS
           8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET
                    TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.4 PERIPHERAL VASCULAR APPLICATION
           8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET
                    TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.5 ONCOLOGY APPLICATIONS
           8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET
                    TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)

9 MICROCATHETERS MARKET, BY END USER (Page No. - 79)
    9.1 INTRODUCTION
           TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS
           9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET
                    TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION)
    9.3 AMBULATORY CARE CENTERS
           9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION
                    TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION)

10 MICROCATHETERS MARKET, BY REGION (Page No. - 83)
     10.1 INTRODUCTION
             TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
             TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate North American market during forecast period
                                      TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market
                                      TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
             TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing aging population and rising life expectancy to boost market
                                      TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.2 FRANCE
                        10.3.2.1 Significant evolution of healthcare sector to drive market
                                      TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market
                                      TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing geriatric population to aid growth
                                      TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing technological developments in healthcare sector to propel market
                                      TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
             TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Increasing geriatric population and surgical procedures to drive market
                                      TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth
                                      TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market
                                      TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market
                                      TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Growing target patient population for cardiovascular diseases to drive market
                                      TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                       TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET
                        TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                        TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET
                        TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)
                        TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 107)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET
     11.3 MARKET RANKING ANALYSIS
             FIGURE 27 MICROCATHETERS MARKET (2021)
             11.3.1 BOSTON SCIENTIFIC CORPORATION
             11.3.2 ASAHI INTECC CO., LTD.
             11.3.3 MEDTRONIC PLC
             11.3.4 TELEFLEX
             11.3.5 TERUMO MEDICAL CORPORATION
     11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET
     11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
             TABLE 80 OVERALL FOOTPRINT OF COMPANIES
             TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)
             TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES)
             TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)
     11.6 COMPANY EVALUATION QUADRANT
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
     11.7 START-UPS/SMES EVALUATION QUADRANT
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 DYNAMIC COMPANIES
             11.7.3 STARTING BLOCKS
             11.7.4 RESPONSIVE COMPANIES
                        FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021)
     11.8 COMPETITIVE SCENARIO
             11.8.1 PRODUCT LAUNCHES AND APPROVALS
                        TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019–2022
             11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
                        TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022

12 COMPANY PROFILES (Page No. - 122)
(Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
     12.1 KEY PLAYERS
             12.1.1 BOSTON SCIENTIFIC CORPORATION
                        TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.2 ASAHI INTECC CO., LTD.
                        TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW
                        FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021)
             12.1.3 MEDTRONIC PLC
                        TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW
                        FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021)
             12.1.4 STRYKER
                        TABLE 89 STRYKER: COMPANY OVERVIEW
                        FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021)
             12.1.5 BECTON, DICKINSON AND COMPANY
                        TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
                        FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             12.1.6 TERUMO MEDICAL CORPORATION
                        TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW
                        FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.7 MERIT MEDICAL SYSTEMS, INC.
                        TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
                        FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
             12.1.8 CARDINAL HEALTH
                        TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW
                        FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
             12.1.9 B. BRAUN MELSUNGEN AG
                        TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
             12.1.10 COOK MEDICAL GROUP
                        TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW
             12.1.11 TELEFLEX
                        TABLE 96 TELEFLEX: COMPANY OVERVIEW
             12.1.12 JOHNSON & JOHNSON
                        TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW
             12.1.13 ANGIODYNAMICS
                        TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW
             12.1.14 PENUMBRA
                        TABLE 99 PENUMBRA: COMPANY OVERVIEW
             12.1.15 BTG PLC
                        TABLE 100 BTG PLC: COMPANY OVERVIEW
             12.1.16 GUERBET LLC
                        TABLE 101 GUERBET LLC: COMPANY OVERVIEW
             12.1.17 EMBOLX INC.
                        TABLE 102 EMBOLX INC.: COMPANY OVERVIEW
             12.1.18 TOKAI MEDICAL
                        TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW
             12.1.19 KANEKA CORPORATION
                        TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT
             12.1.20 INTEGER HOLDINGS CORPORATION
                        TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
             12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD.
                        TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
             12.1.22 MICROVENTION TERUMO
                        TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW
             12.1.23 REFLOW MEDICAL
                        TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW
             12.1.24 SPARTAN MICRO
                        TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW
             12.1.25 TRANSIT SCIENTIFIC
                        TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW
             12.1.26 TRISALUS LIFE SCIENCES, INC.
                        TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 163)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 CUSTOMIZATION OPTIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the microcatheter market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the Microcatheter Market. The primary sources from the demand side include medical OEMs, Oncologists, CDMOs and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Microcatheters Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2019, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 =

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the microcatheter market's size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the microcatheters business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • Generating a list of major global players operating in the microcatheter market.
  • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
  • Revenue mapping of major players to cover major share of the global market share, as of 2021
  • Extrapolating the global value of the microcatheters industry

Microcatheters Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global microcatheter market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the microcatheter market was validated using both top-down and bottom-up approaches.

Objectives of the Study

  • To define, describe, and forecast the Microcatheter market on the basis of product, end user, and region .
  • To provide detailed information regarding the major factors influencing the growth potential of the global Microcatheter market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global Microcatheters Market
  • To analyze key growth opportunities in the global Microcatheter market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Thailand, Indonesia and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
  • To profile the key players in the global Microcatheter market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global Microocatheter  market, such as product launches; agreements; expansions; and mergers & acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global microcatheter report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe Microcatheters Market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific Microcatheters Market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Latin American Microcatheters Market into Colombia, Chile, Argentina, and Peru, among other
Report Code
MD 7015
Published ON
Nov, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Microcatheter Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback